Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1595-2013Class II

INFUSE(R) Bone Graft, LARGE II KIT, REF 7510800AUS, Medtronic Sofamore Danek USA, Inc., 1800 Pyramid Place...

Medtronic Sofamor Danek USA Inc / initiated 2013-05-28 / Terminated / root cause: manufacturing process

Medtronic Sofamor Danek USA Inc began a recall of INFUSE(R) Bone Graft, LARGE II KIT, REF 7510800AUS, Medtronic Sofamore Danek USA, Inc., 1800 Pyramid Place, Memphis, Tennessee 38132 orthopaedic on . FDA classified it as Class II and gives the reason as "Kits contain a collagen sponge recalled by Integra due to possible elevated endotoxin levels resulting from a process deviation". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1595-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Medtronic Sofamor Danek USA Inc
Product
INFUSE(R) Bone Graft, LARGE II KIT, REF 7510800AUS, Medtronic Sofamore Danek USA, Inc., 1800 Pyramid Place, Memphis, Tennessee 38132 orthopaedic
Product code
NEK Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction
Reason for recall
Kits contain a collagen sponge recalled by Integra due to possible elevated endotoxin levels resulting from a process deviation.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
Medtronic on behalf of Integra LifeSciences Corporation sent an Urgent Voluntary Removal (Recall) letter on May 24, 2013, directly to all Risk Managers and Sales Representatives, with Recall Questionnaires and Confirmation forms included. Foreign consignees were notified by email on May 28, 2013. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to remove the product and discontinue use. The letter should be forwarded to surgeons or attending physicians who have used the affected products. Customers were instructed to use the attached questionnaire to account for product in their possession, document which physicians they notified and report any patient injuries that may have occurred related to the use of the affected product by calling the phone number in the questionnaire. Customers were asked to return the questionnaire using the enclosed self-addressed stamped envelope, via their Medtronic Sales Representative or via fax to 763-367-8134 For questions regarding this recall 901-399-3182. Customers were instructed to contact their Medtronic Sales Representative to coordinate the return and replenishment of affected product . Customers with questions should call 800-876-3133, ext 3197.
Quantity in commerce
2090 units
Distribution
Worldwide distribution: USA (nationwide including Puerto Rico) and Internationally to Australia, Brazil, Canada, Chile, Hong Kong, India, Mexico, Netherlands, , New South Wales, Panama, and Paraguay.
Product codes and lots
Lots: M111103AAC, M111052AAT, M111059AAE, M111054AAR, M111052AAM

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1595-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1589-2013Class IITerminatedVoluntary: Firm initiated
Z-1590-2013Class IITerminatedVoluntary: Firm initiated
Z-1591-2013Class IITerminatedVoluntary: Firm initiated
Z-1592-2013Class IITerminatedVoluntary: Firm initiated
Z-1593-2013Class IITerminatedVoluntary: Firm initiated
Z-1594-2013Class IITerminatedVoluntary: Firm initiated
Z-1595-2013Class IITerminatedVoluntary: Firm initiated